Collectively, the lack of association between 25(OH)D, 1,25(OH)2D, iPTH, and FGF-23 levels suggests that mechanisms other than alterations in mineral metabolisms contribute to the decline in cognitive function with advancing CKD. The gene discussed is FGF23; the disease is chronic kidney disease.